Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease of unknown etiology but lymphocytic portal tract infiltration is suggestive of an immune-mediated basis for this disease. Associations with inflammatory bowel disease (IBD) especially ulcerative colitis (UC), and with particular autoimmune diseases, as well as the genetic associations further suggest PSC may be an immune-mediated disease. The immunogenetics of PSC have been the subject of active research and several HLA and non-HLA associated genes have been implicated in the development of the disease. Lymphocytes derived from the inflamed gut may enter the liver via the enterohepatic circulation to cause hepatic disease. PSC may be triggered in genetically susceptible individuals by infections or toxins entering the portal circulation through a permeable colon and hence evoking an abnormal immune response.


Journal article


World J Gastroenterol

Publication Date





3350 - 3359


Antigens, Bacterial, Autoantibodies, Autoimmune Diseases, Bile Ducts, Chemotaxis, Leukocyte, Cholangitis, Sclerosing, Epithelial Cells, Genetic Predisposition to Disease, Humans, Immunity, Cellular, Immunogenetics, Major Histocompatibility Complex, Membrane Transport Proteins, Pancreatitis, Risk Factors, T-Lymphocytes